Orthotopic Heart Transplantation in Patients With Metabolic Risk Factors

被引:25
|
作者
Kilic, Arman
Conte, John V.
Shah, Ashish S.
Yuh, David D. [1 ]
机构
[1] Yale Univ, Sch Med, Sect Cardiac Surg, Dept Surg, New Haven, CT 06510 USA
关键词
DIABETES-MELLITUS; ALLOGRAFT VASCULOPATHY; MORTALITY; SURVIVAL; OBESITY; IMPACT; MANAGEMENT; OVERWEIGHT; RECIPIENTS; MORBIDITY;
D O I
10.1016/j.athoracsur.2011.11.054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The aim of this study was to evaluate the impact of metabolic risk factors on mortality rates after orthotopic heart transplantation (OHT). Methods. Adult patients undergoing OHT between 1998 and 2008 were identified in the United Network for Organ Sharing registry. The impact of metabolic risk factors (hypertension, diabetes mellitus, and obesity) on mortality post-OHT was evaluated in a Cox proportional hazards regression analysis adjusted for other variables associated with survival in univariate analysis (exploratory p value < 0.2). Kaplan-Meier survival estimates were compared with the log-rank test. Results. A total of 15,960 eligible patients underwent OHT during the study period. There were 6,368 (39.9%) patients with none of these risk factors, 6,138 (38.5%) with 1 risk factor, 2,811 (17.6%) with 2 risk factors, and 643 (4.0%) who had all 3 risk factors. After adjusting for other significant variables influencing survival, each in-dividual risk factor independently increased the likelihood of mortality post-OHT (hypertension: HR 1.10 [1.03 to 1.17]; diabetes: HR 1.22[1.13 to 1.31]; obesity: HR 1.17 [1.10 to 1.26], each p < 0.01). There was an exponential trend of increasing mortality with the addition of each risk factor (r(2) = 0.99, p < 0.001) such that patients with all 3 risk factors had a 63% increased mortality compared with those with no risk factors (HR 1.63 [1.42 to 1.88], p < 0.001). There was also a significant trend in declining 5-year survival rates with an increasing number of risk factors: 0 (74.7%), 1 (71.3%), 2 (68.2%), and 3 (63.1%) (p < 0.001). Conclusions. This large-cohort study demonstrates that an increasing number of metabolic risk factors in OHT recipients is associated with exponential increases in postoperative mortality rates. (Ann Thorac Surg 2012;93:718-25) (C) 2012 by The Society of Thoracic Surgeons
引用
收藏
页码:718 / 725
页数:9
相关论文
共 50 条
  • [1] Heart Transplantation and Risk of Cardiac Vasculopathy Development: What Factors Are Important?
    Sobieszczanska-Malek, Malgorzata
    Korewicki, Jerzy
    Komuda, Krzysztof
    Karczmarz, Malgorzata
    Szymanska, Sylwia
    Cicha-Mikolajczyk, Alicja
    Bekta, Pawel
    Parulski, Adam
    Pronicki, Maciej
    Grajkowska, Wieslawa
    Malek, Grzegorz
    Leszek, Przemyslaw
    Kaczorowska, Maria
    Kusmierczyk, Mariusz
    Zielinski, Tomasz
    ANNALS OF TRANSPLANTATION, 2017, 22 : 682 - 688
  • [2] Risk Factors and Cardiovascular Events in Orthotopic Liver Transplantation
    Ali, Asghar
    Mitchell, Brian K.
    Donovan, Robert
    Patel, Samarth S.
    Danyi, Peter
    Giles, Hochong
    Kang, Le
    Fuchs, Michael
    Heuman, Douglas
    Jovin, Ion S.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2023, 32 (01) : 51 - 57
  • [3] Risk factors of acute kidney injury after orthotopic liver transplantation in China
    Yin Zongyi
    Li Baifeng
    Zou Funian
    Li Hao
    Wang Xin
    SCIENTIFIC REPORTS, 2017, 7
  • [4] Simple Score to Assess the Risk of Rejection After Orthotopic Heart Transplantation
    Kilic, Arman
    Weiss, Eric S.
    Allen, Jeremiah G.
    Conte, John V.
    Shah, Ashish S.
    Baumgartner, William A.
    Yuh, David D.
    CIRCULATION, 2012, 125 (24) : 3013 - 3021
  • [5] The prognostic importance of modifiable risk factors after heart transplantation
    Arora, Satish
    Aukrust, Pal
    Andreassen, Arne
    Simonsen, Svein
    Gude, Einar
    Grov, Ingelin
    Geiran, Odd
    Fiane, Arnt
    Guffestad, Lars
    AMERICAN HEART JOURNAL, 2009, 158 (03) : 431 - 436
  • [6] The Effect of Hyponatremia on the Outcome of Patients After Orthotopic Liver Transplantation
    Karapanagiotou, A.
    Kydona, C.
    Papadopoulos, S.
    Dimitriadis, C.
    Giasnetsova, T.
    Rempelakos, G.
    Passakiotou, M.
    Fouzas, I.
    Papanikolaou, V.
    Gritsi-Gerogianni, N.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2724 - 2726
  • [7] A Comprehensive Review on the Risk of Metabolic Syndrome and Cardiovascular Disease after Liver Transplantation
    Chauhan, Kashyap
    Khan, Adnan
    Chowdhury, Salil
    Ross, Heather M.
    Parra, Natalia Salinas
    Halegoua-DeMarzio, Dina
    LIVERS, 2022, 2 (02): : 85 - 96
  • [8] Risk Factors for Transfusion after Orthotopic Liver Transplantation
    Hitonni Yokoyama, Ana Paula
    Kutner, Jose Mauro
    Sakashita, Araci Massami
    Nakazawa, Cristiane Yoshie
    Omura de Paula, Tatiana Almeida
    Cezar Zamper, Raffael Perreira
    Pedroso, PanneIla Tung
    de Almeida, Marcio Dias
    Meira Filho, Sergio Paiva
    Orsi, Fernanda Andrade
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2019, 46 (06) : 431 - 439
  • [9] Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation
    Heil, Karsten M.
    Helmschrott, Matthias
    Darche, Fabrice F.
    Bruckner, Tom
    Ehlermann, Philipp
    Kreusser, Michael M.
    Doesch, Andreas O.
    Sommer, Wiebke
    Warnecke, Gregor
    Frey, Norbert
    Rivinius, Rasmus
    LIFE-BASEL, 2021, 11 (12):
  • [10] Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States
    Krishnamurthy, Yamini
    Cooper, Lauren B.
    Lu, Di
    Schroder, Jacob N.
    Daneshmand, Mani A.
    Rogers, Joseph G.
    Milano, Carmelo A.
    Hernandez, Adrian F.
    Patel, Chetan B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (05) : 619 - 624